| Application no. and date | 11737745.7 (espacenet) (Federated) (European Patent Register), 20110128 | | Patent/reg. no. and date | DK/EP 2528602, 20161005 | | Publication date | 20121205 | | Priority no. and date | US 299100 P, 20100128 | | EP pub. no. and date |
EP 2528602 20121205 | | Effective date | | | Applicant/owner | Eagle Pharmaceuticals, Inc., 50 Tice Boulevard
Woodcliff Lake, NJ 07677, US | | Applicant ref. no. | P72697DK01 | | Inventor | BUXTON, Philip Christopher, 11 Bradley Close
Great Dunmow Essex CM6 2PB, GB,
PALEPU, Nagesh R., 30 Addis Drive
Southampton, Pennsylvania 18966, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61K 47/10 (2017.01) , A61K 47/20 (2006.01) , A61K 9/08 (2006.01) | | Title | FORMULERINGER AF BENDAMUSTIN | | Int. application no. | US2011022958 | | Int. publication no. | WO2011094565 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
